Literature DB >> 35087171

Efficient recovery of potent tumour-infiltrating lymphocytes through quantitative immunomagnetic cell sorting.

Zongjie Wang1,2, Sharif Ahmed3, Mahmoud Labib3, Hansen Wang3, Xiyue Hu3, Jiarun Wei4,5, Yuxi Yao4,5, Jason Moffat4,5, Edward H Sargent1, Shana O Kelley6,7,8,9,10.   

Abstract

Adoptive cell therapies require the recovery and expansion of highly potent tumour-infiltrating lymphocytes (TILs). However, TILs in tumours are rare and difficult to isolate efficiently, which hinders the optimization of therapeutic potency and dose. Here we show that a configurable microfluidic device can efficiently recover potent TILs from solid tumours by leveraging specific expression levels of target cell-surface markers. The device, which is sandwiched by permanent magnets, balances magnetic forces and fluidic drag forces to sort cells labelled with magnetic nanoparticles conjugated with antibodies for the target markers. Compared with conventional cell sorting, immunomagnetic cell sorting recovered up to 30-fold higher numbers of TILs, and the higher levels and diversity of the recovered TILs accelerated TIL expansion and enhanced their therapeutic potency. Immunomagnetic cell sorting also allowed us to identify and isolate potent TIL subpopulations, in particular TILs with moderate levels of CD39 (a marker of T-cell reactivity to tumours and T-cell exhaustion), which we found are tumour-specific, self-renewable and essential for the long-term success of adoptive cell therapies.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35087171     DOI: 10.1038/s41551-021-00820-y

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   29.234


  76 in total

1.  Pursuit of tumor-infiltrating lymphocyte immunotherapy speeds up.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2019-09       Impact factor: 54.908

Review 2.  Nanomaterials for T-cell cancer immunotherapy.

Authors:  Ningqiang Gong; Neil C Sheppard; Margaret M Billingsley; Carl H June; Michael J Mitchell
Journal:  Nat Nanotechnol       Date:  2021-01-12       Impact factor: 39.213

Review 3.  Cell transfer immunotherapy for metastatic solid cancer--what clinicians need to know.

Authors:  Steven A Rosenberg
Journal:  Nat Rev Clin Oncol       Date:  2011-08-02       Impact factor: 66.675

Review 4.  Cancer immunotherapy comes of age.

Authors:  Ira Mellman; George Coukos; Glenn Dranoff
Journal:  Nature       Date:  2011-12-21       Impact factor: 49.962

Review 5.  Developing neoantigen-targeted T cell-based treatments for solid tumors.

Authors:  Tori N Yamamoto; Rigel J Kishton; Nicholas P Restifo
Journal:  Nat Med       Date:  2019-10-07       Impact factor: 53.440

6.  Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.

Authors:  Eric Tran; Simon Turcotte; Alena Gros; Paul F Robbins; Yong-Chen Lu; Mark E Dudley; John R Wunderlich; Robert P Somerville; Katherine Hogan; Christian S Hinrichs; Maria R Parkhurst; James C Yang; Steven A Rosenberg
Journal:  Science       Date:  2014-05-09       Impact factor: 47.728

7.  Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.

Authors:  Mark E Dudley; John R Wunderlich; Paul F Robbins; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne L Topalian; Richard Sherry; Nicholas P Restifo; Amy M Hubicki; Michael R Robinson; Mark Raffeld; Paul Duray; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White; Steven A Rosenberg
Journal:  Science       Date:  2002-09-19       Impact factor: 47.728

8.  A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.

Authors:  S A Rosenberg; P Spiess; R Lafreniere
Journal:  Science       Date:  1986-09-19       Impact factor: 47.728

9.  Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.

Authors:  Rikke Andersen; Marco Donia; Eva Ellebaek; Troels Holz Borch; Per Kongsted; Trine Zeeberg Iversen; Lisbet Rosenkrantz Hölmich; Helle Westergren Hendel; Özcan Met; Mads Hald Andersen; Per Thor Straten; Inge Marie Svane
Journal:  Clin Cancer Res       Date:  2016-03-22       Impact factor: 12.531

10.  DNA scaffolds enable efficient and tunable functionalization of biomaterials for immune cell modulation.

Authors:  Xiao Huang; Jasper Z Williams; Ryan Chang; Zhongbo Li; Cassandra E Burnett; Rogelio Hernandez-Lopez; Initha Setiady; Eric Gai; David M Patterson; Wei Yu; Kole T Roybal; Wendell A Lim; Tejal A Desai
Journal:  Nat Nanotechnol       Date:  2020-12-14       Impact factor: 40.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.